Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: The Erasmus Rucphen family study

European Journal of Epidemiology

Volumn 22, Issue 2, 2007, Pages 99-105

  Isaacs, Aaron ^a   Sayed Tabatabaei, Fakhredin A ^a   Aulchenko, Yurii S ^a   Zillikens, M Carola ^a   Sijbrands, Eric J G ^a   Schut, Anna F C ^a   Rutten, Wim P F ^b   Pols, Huibert A P ^a   Witteman, Jacqueline C M ^a   Oostra, Ben A ^a   Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Stichting Huisarts Laboratorium   (Netherlands)

Author keywords

ApoE; Cholesterol; Extended pedigree; HDL; Inbreeding; LDL; Triglycerides

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE ISOLATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HERITABILITY; HUMAN; INBREEDING; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PEDIGREE; PHENOTYPE; POPULATION GENETICS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS E; COHORT STUDIES; CONSANGUINITY; DYSLIPIDEMIAS; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION GROUPS;

EID: 33947361947     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9103-0     Document Type: Article

References (35)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285: 2486-2497.
3. LaRosa JC, Gotto AM Jr. Past, present, and future standards for management of dyslipidemia. Am J Med 2004; 116(Suppl 6A): 3S-8S.
4. Despres JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 2000; 153: 263-272.
5. Abney M, McPeek MS, Ober C. Broad and narrow heritabilities of quantitative traits in a founder population. Am J Hum Genet 2001; 68: 1302-1307.
6. Hokanson JE, Langefeld CD, Mitchell BD, Lange LA, Goff DC Jr. Haffner SM, Saad MF, Rotter JI. Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: the IRAS Family Study. Hum Hered 2003; 55: 46-50.
7. Chien KL, Hsu HC, Su TC, Yang CY, Lee YT. Consistency of genetic inheritance mode and heritability patterns of triglyceride vs. high density lipoprotein cholesterol ratio in two Taiwanese family samples. BMC Genet 2003; 4: 7.
8. Edwards KL, Mahaney MC, Motulsky AG, Austin MA. Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families. Arterioscler Thromb Vasc Biol 1999; 19: 2456-2464.
9. Ober C, Abney M, McPeek MS. The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001; 69: 1068-1079.
10. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 1996; 94: 2159-2170.
11. Perusse L, Rice T, Despres JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, et al. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol 1997; 17: 3263-3269.
12. Brenn T. Genetic and environmental effects on coronary heart disease risk factors in northern Norway. The cardiovascular disease study in Finnmark. Ann Hum Genet 1994; 58(Pt 4): 369-379.
13. Wu KD, Hsiao CF, Ho LT, Sheu WH, Pei D, Chuang LM, Curb D, Chen YD, Tsai HJ, Dzau VJ, et al. Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance sibling study. Hypertens Res 2002; 25: 529-536.
14. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 2002; 19: 994-999.
15. Iliadou A, Snieder H, Wang X, Treiber FA, Davis CL. Heritabilities of lipids in young European American and African American twins. Twin Res Hum Genet 2005; 8: 492-498.
16. Fenger M, Schousboe K, Sorensen TI, Kyvik KO. Variance decomposition of apolipoproteins and lipids in Danish twins. Atherosclerosis 2006.
17. Mahley RW, Innerarity TL, Rall SC Jr. Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984; 25: 1277-1294.
18. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002; 155: 487-495.
19. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985; 37: 268-285.
20. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 1992; 33: 447-454.
21. Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnohr P, Tybjaerg-Hansen A. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res 2000; 41: 1812-1822.
22. Ribalta J, Vallve JC, Girona J, Masana L. Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care 2003; 6: 177-187.
23. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993; 71: 160-165.
24. Mahley RW, Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol 1999; 10: 207-217.
25. Pausova Z, Jomphe M, Houde L, Vezina H, Orlov SN, Gossard F, Gaudet D, Tremblay J, Kotchen TA, Cowley AW, et al. A genealogical study of essential hypertension with and without obesity in French Canadians. Obes Res 2002; 10: 463-470.
26. Rudan I, Rudan D, Campbell H, Carothers A, Wright A, Smolej-Narancic N, Janicijevic B, Jin L, Chakraborty R, Deka R, et al. Inbreeding and risk of late onset complex disease. J Med Genet 2003; 40: 925-932.
27. Rudan I, Smolej-Narancic N, Campbell H, Carothers A, Wright A, Janicijevic B, Rudan P. Inbreeding and the genetic complexity of human hypertension. Genetics 2003; 163: 1011-1021.
28. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (2002)25:5S-20.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
30. Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Muller J, Schomig A, Kastrati A. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med 2002; 40: 1123-1131.
31. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
32. Boichard D. PEDIG: A FORTRAN package for pedigree analysis studied for large populations. In 7th World Congr. Genet. Appl. Livest. Prod.; Montpelier, FR: 2002.
33. Farrer LA, Cupples LA. Determining the Genetic Component of a Disease, . In: Haines JL (ed.) Approaches to Gene Mapping in Complex Human Diseases. Pericak-Vance MA: John Wiley & Sons, Inc, 1998, p. 93-131.
34. Abney M, McPeek MS, Ober C. Estimation of variance components of quantitative traits in inbred populations. Am J Hum Genet 2000; 66: 629-650.
35. Fay JC, Wyckoff GJ, Wu CI. Positive and negative selection on the human genome. Genetics 2001; 158: 1227-1234.